Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rothenberg

Showing results (321-330 of 658) with videos related to

Pageof 66
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loopCarine Bouffi, Mark Rochman, Christopher B Zust, et al.
Allergy|February 16, 2023
Protease allergens as initiators-regulators of allergic inflammationWai Tuck Soh, Jihui Zhang, Morley D Hollenberg, et al.
The Journal of Biological Chemistry|September 25, 1988
Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factorM E Rothenberg, J L Pomerantz, W F Owen, et al.
Blood|January 19, 2006
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like diseaseYoshiyuki Yamada, Marc E Rothenberg, Andrew W Lee, et al.
The Journal of Allergy and Clinical Immunology|April 16, 2008
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levelsMiguel L Stein, Joyce M Villanueva, Bridget K Buckmeier, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 9, 2020
Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthoodEvan S Dellon, Olivia Shaheen, Nathaniel T Koutlas, et al.
The Journal of Clinical Investigation|June 1, 1988
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3M E Rothenberg, W F Owen, D S Silberstein, et al.
The American Journal of Pathology|July 1, 1990
A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitroJ P Caulfield, A Hein, M E Rothenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicityM E Rothenberg, J Petersen, R L Stevens, et al.
European Journal of Clinical Nutrition|May 8, 2014
Nutrition impact symptoms and body composition in patients with COPDJ Nordén, A M Grönberg, I Bosaeus, et al.
Pageof 66

Showing results (321-330 of 658) with videos related to

Sort By:
Pageof 66
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loopCarine Bouffi, Mark Rochman, Christopher B Zust, et al.
Allergy|February 16, 2023
Protease allergens as initiators-regulators of allergic inflammationWai Tuck Soh, Jihui Zhang, Morley D Hollenberg, et al.
The Journal of Biological Chemistry|September 25, 1988
Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factorM E Rothenberg, J L Pomerantz, W F Owen, et al.
Blood|January 19, 2006
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like diseaseYoshiyuki Yamada, Marc E Rothenberg, Andrew W Lee, et al.
The Journal of Allergy and Clinical Immunology|April 16, 2008
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levelsMiguel L Stein, Joyce M Villanueva, Bridget K Buckmeier, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 9, 2020
Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthoodEvan S Dellon, Olivia Shaheen, Nathaniel T Koutlas, et al.
The Journal of Clinical Investigation|June 1, 1988
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3M E Rothenberg, W F Owen, D S Silberstein, et al.
The American Journal of Pathology|July 1, 1990
A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitroJ P Caulfield, A Hein, M E Rothenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicityM E Rothenberg, J Petersen, R L Stevens, et al.
European Journal of Clinical Nutrition|May 8, 2014
Nutrition impact symptoms and body composition in patients with COPDJ Nordén, A M Grönberg, I Bosaeus, et al.
Pageof 66